safety of lenalidomide maintenance therapy in myeloma patients following transplantation
Published 2 years ago • 790 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:30
the impact of lenalidomide maintenance therapy on myeloma patients in the uk
-
2:21
lenalidomide maintenance therapy in patients with multiple myeloma and high-risk cytogenetics
-
2:31
evaluating the safety of maintenance therapy cessation in mrd negative myeloma patients
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
1:35
the impact of frontline maintenance therapy on myeloma patients in the uk
-
2:24
myeloma: lenalidomide maintenance therapy
-
1:08
lenalidomide maintenance in mm: data update
-
6:23
results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
-
4:35
dose reduction of selinexor in combination with bortezomib and dexamethasone in multiple myeloma
-
6:20
panel discusses maintenance therapy and the changing landscape for early-relapse multiple myeloma
-
0:52
is there a role for combination therapy in cml?
-
1:27
maintenance therapy and mrd in myeloma
-
1:47
post-authorization safety of lenalidomide dexamethasone in patients with multiple myeloma in turkey
-
4:06
single-agent lenalidomide maintenance after upfront autosct in newly diagnosed multiple myeloma
-
1:13
majestec-4: teclistamab lenalidomide vs lenalidomide as maintenance therapy in ndmm
-
2:02
evaluating the optimal duration of lenalidomide maintenance after autosct using data from myeloma xi
-
1:13
real-world efficacy and safety of selinexor in r/r multiple myeloma
-
1:21
vrd induction, mel200-conditioned autohsct and lenalidomide maintenance in multiple myeloma
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma
-
1:56
defining the optimal duration of maintenance therapy for multiple myeloma
-
2:22
myeloma xi trial: lenalidomide maintenance therapy for multiple myeloma
-
1:07
lenalidomide maintenance – an active approach to treating mm?